RenovoRx, Inc. (RNXT)
NASDAQ: RNXT · Real-Time Price · USD
1.280
-0.070 (-5.19%)
At close: Jun 27, 2025, 4:00 PM
1.320
+0.040 (3.13%)
After-hours: Jun 27, 2025, 6:40 PM EDT
RenovoRx Market Cap
RenovoRx has a market cap or net worth of $46.81 million as of June 27, 2025. Its market cap has increased by 89.75% in one year.
Market Cap
46.81M
Enterprise Value
32.51M
1-Year Change
89.75%
Ranking
Category
Stock Price
$1.28
Market Cap Chart
Since the IPO on August 26, 2021, RenovoRx's market cap has decreased from $68.64M to $46.81M, a decrease of -31.80%. That is a compound annual growth rate of -9.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 49.37M | 59.46% |
| Dec 31, 2024 | 30.96M | 26.43% |
| Dec 29, 2023 | 24.49M | 14.54% |
| Dec 30, 2022 | 21.38M | -50.41% |
| Dec 31, 2021 | 43.12M | -37.19% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.28B |
| Johnson & Johnson | 366.40B |
| AbbVie | 327.47B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.97B |
| Abbott Laboratories | 239.05B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |